Interpretation of microarray data in cancer
- PMID: 17342085
- PMCID: PMC2360153
- DOI: 10.1038/sj.bjc.6603673
Interpretation of microarray data in cancer
Abstract
Microarray studies aim at identifying homogeneous subtypes of cancer patients, searching for differentially expressed genes in tumours with different characteristics, or predicting the prognosis of patients. Using breast cancer as an example, we discuss the hypotheses underlying these studies, their power, and the validity and the clinical usefulness of the findings.
References
-
- Allison DB, Cui X, Page GP, Sabripour M (2006) Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 7: 55–65 - PubMed
-
- Altman DG, Royston P (2000) What do we mean by validating a prognostic model? Stat Med 19: 453–473 - PubMed
-
- Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate – a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57: 289–300
-
- Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418: 823. - PubMed
-
- Braga-Neto UM, Dougherty ER (2004) Is cross-validation valid for small-sample microarray classification? Bioinformatics 20: 374–380 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
